I have been working with other False Claims Act attorneys at Greene LLP since 2010, specializing in whistleblower litigation since that time. In 2011, Tom Greene and I filed one of the first False Claims Act cases involving customs duties, a valuation case brought to successful resolution with a knowledgeable, dedicated whistleblower and one page of evidence.

Like my partners at Greene LLP, my experience in False Claims Act Litigation is broad, stretching across a variety of industries, and involving significant court victories at the appellate level — including the Supreme Court — that has shaped False Claims Act jurisprudence. The Greene LLP team has an unusually high level of experience actually litigating False Claims Act cases that have been declined by the United States, including the 2012-2022 Biogen litigation that resulted in the largest whistleblower award in the history of the statute. Our firm has always preferred a low-volume, high-effort approach, and that has helped us amass a type of experience that few other firms have had. In the wake of the $264M whistleblower award in Biogen, that secret is out — but our practice has only become more focused.

During this time, I’ve kept coming back to the customs area again and again, with other good FCA results, leading to licensure as a customs broker. In my spare and professional time, I have worked tirelessly to learn international trade’s intricacies — and I feel uniquely qualified to reconcile them with the intricacies of False Claims Act practice, representing whistleblowers. Due in large part to this special interest, I will always try my best to make time to research and talk through any trade issue that has False Claims Act implications. You can reach me at (617) 261-0040 or rmorrison@greenellp.com.